AstraZeneca PLC

AstraZeneca PLCverified

AZNCF

Price:

$163.97

Market Cap:

$254.20B

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/On...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2009-02-13

Stock Exchange

PNK

Ticker

AZNCF

The Enterprise Value as of September 2024 (TTM) for AstraZeneca PLC (AZNCF) is 280.82B

According to AstraZeneca PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 280.82B. This represents a change of 15.60% compared to the average of 242.93B of the last 4 quarters.

AstraZeneca PLC (AZNCF) Historical Enterprise Value (quarterly & annually)

How has AZNCF Enterprise Value performed in the past?

The mean historical Enterprise Value of AstraZeneca PLC over the last ten years is 141.51B. The current 280.82B Enterprise Value has changed 19.74% with respect to the historical average. Over the past ten years (40 quarters), AZNCF's Enterprise Value was at its highest in in the June 2024 quarter at 270.75B. The Enterprise Value was at its lowest in in the December 2016 quarter at 79.94B.

Quarterly (TTM)
Annual

Average

141.51B

Median

125.77B

Minimum

79.94B

Maximum

233.93B

AstraZeneca PLC (AZNCF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AstraZeneca PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 34.47%

Maximum Annual Enterprise Value = 233.93B

Minimum Annual Increase = -15.25%

Minimum Annual Enterprise Value = 79.94B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023231.01B-1.25%
2022233.93B23.95%
2021188.73B30.10%
2020145.06B0.56%
2019144.26B34.47%
2018107.28B11.50%
201796.22B20.37%
201679.94B-15.25%
201594.32B-0.08%
201494.40B26.14%

AstraZeneca PLC (AZNCF) Average Enterprise Value

How has AZNCF Enterprise Value performed in the past?

The current Enterprise Value of AstraZeneca PLC (AZNCF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

217.89B

5-year avg

188.60B

10-year avg

141.51B

AstraZeneca PLC (AZNCF) Enterprise Value vs. Peers

How is AZNCF’s Enterprise Value compared to its peers?

AstraZeneca PLC’s Enterprise Value is greater than Roche Holding AG (245.45B), greater than Roche Holding AG (246.72B), greater than Roche Holding AG (245.70B), greater than Grifols, S.A. (14.90B), less than Astellas Pharma Inc. (0), less than Astellas Pharma Inc. (3.78T), less than Bayer Aktiengesellschaft (3.90T), greater than Bristol-Myers Squibb Company PFD CONV 2 (71.14B), greater than Daiichi Sankyo Company, Limited (149.06B), less than Novartis AG (9.19T), greater than Sanofi (236.64B), greater than null (147.83B),

Build a custom stock screener for AstraZeneca PLC (AZNCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AstraZeneca PLC using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AstraZeneca PLC (AZNCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AstraZeneca PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AstraZeneca PLC's Enterprise Value?

What is the highest Enterprise Value for AstraZeneca PLC (AZNCF)?

What is the 3-year average Enterprise Value for AstraZeneca PLC (AZNCF)?

What is the 5-year average Enterprise Value for AstraZeneca PLC (AZNCF)?

How does the current Enterprise Value for AstraZeneca PLC (AZNCF) compare to its historical average?